BioLife Solutions

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$28,067
$25,421
$23,941
$-3,424
Gross Profit
18,779
16,433
15,786
8,271
EBITDA
2,546
-14,330
166
6,747
EBIT
1,211
-15,712
-1,218
5,043
Net Income
621
-15,838
-448
12,459
Net Change In Cash
28,067
25,421
23,941
-3,424
Free Cash Flow
2,802
5,625
1,552
583
Cash
29,481
31,902
66,945
95,386
Basic Shares
48,723
47,798
47,134
48,032

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$82,254
$143,271
$76,239
$119,156
Gross Profit
53,671
46,752
53,822
37,748
EBITDA
1,532
-45,238
-124,182
-16,654
EBIT
-7,129
-57,533
-144,140
-29,519
Net Income
-20,184
-66,427
-139,805
-8,908
Net Change In Cash
82,254
143,271
76,239
119,156
Free Cash Flow
5,204
-18,879
-18,874
-13,221
Cash
95,386
27,896
19,442
69,870
Basic Shares
46,067
43,719
42,481
38,503

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$0.04
2025-06-30
-$0.33
2025-03-31
$0.03